According to the new market
research "Autoimmune
Disease Diagnosis Market by Products (Consumables, Assay Kits,
Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies),
Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical
Labs) - Global Forecast to 2022" published by MarketsandMarkets.
The autoimmune disease diagnosis market is expected to reach USD 4.73
Billion by 2022 from USD 3.09 Billion in 2017, at a CAGR of 8.9%. Factors
driving the growth of this market include high incidence and large economic
burden of autoimmune diseases, increasing healthcare expenditure, and growing
access to medical insurance in the US.
Speak to our analyst and gain crucial industry insights that will
help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=174826519
Consumables
and assay kits are estimated to account for the largest share of the market in
2017
By
product and service, the autoimmune disease diagnosis market is classified into
consumables & assay kits, instruments and services. The consumables &
assay kits segment is expected to lead the global autoimmune disease diagnosis
in 2017. Factors driving the growth of this segment include increasing adoption
of consumables in hospitals and clinical laboratories, rising incidence of
autoimmune diseases, and increasing demand for quick results.
Routine
laboratory tests are estimated to command the largest share of the market
during the forecast period
On the
basis of test type, the autoimmune disease diagnosis market is categorized into
routine laboratory tests, inflammatory markers, autoantibodies and immunologic
tests, and other tests. In 2017, the routine laboratory tests segment is
estimated to account for the largest share of the global autoimmune disease
diagnosis market. The increasing incidence autoimmune diseases, along with
increasing adoption of routine laboratory tests for a variety of diseases are
the key factors driving the growth of this end-user segment.
Browse and in-depth TOC on “Autoimmune Disease Diagnosis
Market "
64 – Tables
36 – Figures
121 - Pages
View more
detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/autoimmune-disease-diagnosis-market-174826519.html
Clinical laboratories are estimated to command
the largest share of the market during the forecast period
Based on end user, the autoimmune disease diagnosis market is
categorized into clinical laboratories, hospitals, and other end users. The
clinical laboratories segment is estimated to account for the largest share of
the global autoimmune disease diagnosis market during the forecast period. The
heavy burden of autoimmune diseases, along with the accessibility and
availability of diagnosis and treatment instruments in clinical laboratories in
a short period of time are the key factors driving the growth of this end-user
segment.
North America is estimated to command the largest
share of the market
Based on region, the autoimmune disease diagnosis market is
segmented into North America, Europe, Asia, and the Rest of the World (RoW).
North America is expected to dominate the autoimmune disease diagnosis market
in 2017. This is attributed to factors such as accessibility to advanced
technologies and opportunities for advanced autoimmune diagnostic testing and
screening, growing incidence of autoimmune diseases, and technological
advancements of autoimmune disease diagnosis in the region as compared to other
regions.
Request for Free
Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=174826519
Market Players
Key players in the autoimmune disease diagnosis market include Thermo
Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens
(Germany), Bio-Rad Laboratories. (US), and Abbott (US).
Comments
Post a Comment